Paper

Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants.

Published Apr 24, 2008 · DOI · S. Gatchalian, Yafu Yao, B. Zhou

Vaccine

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCTLarge Human Trial

Study Snapshot

Live, attenuated Japanese encephalitis vaccine and measles vaccine administered together are well-tolerated and immunogenic in infants younger than 1 year of age, facilitating their incorporation into routine immunization schedules.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants.

References

Citations